These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29966173)

  • 1. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats.
    Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats.
    Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
    Eur J Pharmacol; 2018 Jan; 818():228-234. PubMed ID: 29107672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats.
    Nozu T; Miyagishi S; Kumei S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol Hepatol; 2018 Jan; 33(1):232-239. PubMed ID: 28440889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Biomed Pharmacother; 2021 Jul; 139():111649. PubMed ID: 33957565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Pharmacol Sci; 2019 Jan; 139(1):46-49. PubMed ID: 30522964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Neuropeptides; 2022 Aug; 94():102248. PubMed ID: 35526468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
    Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
    World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Gastroenterol; 2017 Jan; 52(1):72-80. PubMed ID: 27075754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.
    Nozu T; Miyagishi S; Nozu R; Ishioh M; Takakusaki K; Okumura T
    J Pharmacol Sci; 2021 Jul; 146(3):121-124. PubMed ID: 34030794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grape Seed Extract Eliminates Visceral Allodynia and Colonic Hyperpermeability Induced by Repeated Water Avoidance Stress in Rats.
    Arie H; Nozu T; Miyagishi S; Ida M; Izumo T; Shibata H
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
    J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotensin receptor 1 agonist PD149163 alleviates visceral hypersensitivity and colonic hyperpermeability in rat irritable bowel syndrome model.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2024 Dec; 36(12):e14925. PubMed ID: 39314062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin prevents colonic barrier dysfunction by inhibiting mast cell activation in maternal separation-induced IBS-like rats.
    Li Y; Yang T; Yao Q; Li S; Fang E; Li Y; Liu C; Li W
    Neurogastroenterol Motil; 2019 May; 31(5):e13556. PubMed ID: 30740845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water avoidance stress induces visceral hyposensitivity through peripheral corticotropin releasing factor receptor type 2 and central dopamine D2 receptor in rats.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    Neurogastroenterol Motil; 2016 Apr; 28(4):522-31. PubMed ID: 26662216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.